NRG1 and amyotrophic lateral sclerosis: Nevertheless, we must leave open the possibility that, compared to persistent overexpression, modulating NRG1 levels in a more restricted temporal-spatial manner could be beneficial for the treatment of distinct aspects of MN degeneration in ALS.